Avanos Medical, Inc. (NYSE: AVNS) reported Q3 EPS of $0.37, $0.11 better than the analyst estimate of $0.26. Revenue for the quarter came in at $165 million versus the consensus estimate of $166.66 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2018 EPS of $1.75-$1.90, versus the consensus of $0.65.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.